Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours (Q74326929)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Jean-Jacques Patard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Alejandro Rodriguez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Emmanuelle Leray

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Nathalie Rioux-Leclercq

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

François Guillé

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Bernard Lobel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

635-41; discussion 642

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

Multivariate analysis of the prognostic factors of primary superficial bladder cancer

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Cystectomy for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Radical cystectomy--often too late?

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Superficial bladder cancer: progression and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

T1 GIII bladder cancer. Management with transurethral resection only

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Intravesical bacillus Calmette-Guérin treatment for Stage T1 grade 3 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900173-2

7 January 2021

10.1016/S0302-2838(02)00173-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074781%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference